HealthMore in Health→
Experimental once-daily antiviral shows promise against measles and parainfluenza
Key Takeaways
- Researchers identified oral clinical candidate GHP-88310 for orthoparamyxovirus infections.
- The study reports efficacy in rodent and non-rodent animal models.
- Potential targets include parainfluenzaviruses and measles virus.
DE
DT Editorial Team··via medicalxpress.com